United Therapeutics holds the cleaner structural position, with growth as the main driver and stability adding further support. Partners still has the edge on growth, which keeps the comparison from looking entirely one-sided. On the market side, United Therapeutics is in better shape — its trend is intact while Partners's trend has broken down. That puts structure and market broadly in agreement — United Therapeutics's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (PGHN.SW: STOXX 600, UTHR: Russell 1000).
The page question resolves through growth, where Partners Group Holding AG holds the stronger read even though the broader score still favours United Therapeutics Corporation.
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
This level of similarity points to a meaningful structural match, though not a tight one.
The match is driven mainly by margin consistency and revenue growth trajectory.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
United Therapeutics Corporation and Partners Group Holding AG look relatively close on structure, but the price setup still leans toward United Therapeutics Corporation.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where PGHN.SW and UTHR each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The current lead is backed by a stronger multi-year growth trajectory.
Partners Group Holding AG still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.
Growth is the clearest driver of the lead, with stability adding further support — though growth still provides a real counterweight.
Break down the PGHN.SW vs UTHR comparison across all dimensions with the full interactive tool.
Explore how PGHN.SW and UTHR each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.